Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshihiko Doi

Showing results (51-60 of 247) with videos related to

Pageof 25
Sort By:
British Journal of Pharmacology|November 15, 2022
Quantitative analysis of drug distribution in heterogeneous tissues using dual-stacking capillary electrophoresis-mass spectrometryShigehiro Koganemaru, Takayuki Kawai, Hirobumi Fuchigami, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|April 27, 2023
Body weight loss as a prognostic and predictive factor in previously treated patients with metastatic gastric cancer: post hoc analyses of the randomized phase III TAGS trialMichele Ghidini, Howard Hochster, Toshihiko Doi, et al.
International Journal of Cancer|October 26, 2011
Photodynamic therapy as salvage treatment for local failure after chemoradiotherapy in patients with esophageal squamous cell carcinoma: a phase II studyTomonori Yano, Manabu Muto, Keiko Minashi, et al.
European Journal of Cancer (Oxford, England : 1990)|September 20, 2019
Efficacy and safety of TAS-116, an oral inhibitor of heat shock protein 90, in patients with metastatic or unresectable gastrointestinal stromal tumour refractory to imatinib, sunitinib and regorafenib: a phase II, single-arm trialToshihiko Doi, Yukinori Kurokawa, Akira Sawaki, et al.
International Journal of Clinical Oncology|January 12, 2012
Evaluation of safety, pharmacokinetics, and efficacy of vorinostat, a histone deacetylase inhibitor, in the treatment of gastrointestinal (GI) cancer in a phase I clinical trialToshihiko Doi, Tetsuya Hamaguchi, Kuniaki Shirao, et al.
Japanese Journal of Clinical Oncology|March 1, 2026
Study protocol for a phase I investigator-initiated clinical trial of E7820 in Japanese patients with unresectable solid tumours: CIRCUS trial (NCCH2303)Mao Okada, Jun Sato, Chikako Funasaka, et al.
Cancer Chemotherapy and Pharmacology|June 23, 2019
Phase I study of ipatasertib as a single agent and in combination with abiraterone plus prednisolone in Japanese patients with advanced solid tumorsToshihiko Doi, Yutaka Fujiwara, Nobuaki Matsubara, et al.
Japanese Journal of Clinical Oncology|March 17, 2009
A phase 2 clinical trial of panitumumab monotherapy in Japanese patients with metastatic colorectal cancerKei Muro, Takayuki Yoshino, Toshihiko Doi, et al.
American Journal of Clinical Oncology|December 20, 2007
A retrospective study of definitive chemoradiotherapy for elderly patients with esophageal cancerSatoshi Takeuchi, Atsushi Ohtsu, Toshihiko Doi, et al.
Cancer Science|August 13, 2018
Phase I dose-escalation trial of Sym004, an anti-EGFR antibody mixture, in Japanese patients with advanced solid tumorsTakashi Kojima, Kentaro Yamazaki, Ken Kato, et al.
Pageof 25

Showing results (51-60 of 247) with videos related to

Sort By:
Pageof 25
British Journal of Pharmacology|November 15, 2022
Quantitative analysis of drug distribution in heterogeneous tissues using dual-stacking capillary electrophoresis-mass spectrometryShigehiro Koganemaru, Takayuki Kawai, Hirobumi Fuchigami, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|April 27, 2023
Body weight loss as a prognostic and predictive factor in previously treated patients with metastatic gastric cancer: post hoc analyses of the randomized phase III TAGS trialMichele Ghidini, Howard Hochster, Toshihiko Doi, et al.
International Journal of Cancer|October 26, 2011
Photodynamic therapy as salvage treatment for local failure after chemoradiotherapy in patients with esophageal squamous cell carcinoma: a phase II studyTomonori Yano, Manabu Muto, Keiko Minashi, et al.
European Journal of Cancer (Oxford, England : 1990)|September 20, 2019
Efficacy and safety of TAS-116, an oral inhibitor of heat shock protein 90, in patients with metastatic or unresectable gastrointestinal stromal tumour refractory to imatinib, sunitinib and regorafenib: a phase II, single-arm trialToshihiko Doi, Yukinori Kurokawa, Akira Sawaki, et al.
International Journal of Clinical Oncology|January 12, 2012
Evaluation of safety, pharmacokinetics, and efficacy of vorinostat, a histone deacetylase inhibitor, in the treatment of gastrointestinal (GI) cancer in a phase I clinical trialToshihiko Doi, Tetsuya Hamaguchi, Kuniaki Shirao, et al.
Japanese Journal of Clinical Oncology|March 1, 2026
Study protocol for a phase I investigator-initiated clinical trial of E7820 in Japanese patients with unresectable solid tumours: CIRCUS trial (NCCH2303)Mao Okada, Jun Sato, Chikako Funasaka, et al.
Cancer Chemotherapy and Pharmacology|June 23, 2019
Phase I study of ipatasertib as a single agent and in combination with abiraterone plus prednisolone in Japanese patients with advanced solid tumorsToshihiko Doi, Yutaka Fujiwara, Nobuaki Matsubara, et al.
Japanese Journal of Clinical Oncology|March 17, 2009
A phase 2 clinical trial of panitumumab monotherapy in Japanese patients with metastatic colorectal cancerKei Muro, Takayuki Yoshino, Toshihiko Doi, et al.
American Journal of Clinical Oncology|December 20, 2007
A retrospective study of definitive chemoradiotherapy for elderly patients with esophageal cancerSatoshi Takeuchi, Atsushi Ohtsu, Toshihiko Doi, et al.
Cancer Science|August 13, 2018
Phase I dose-escalation trial of Sym004, an anti-EGFR antibody mixture, in Japanese patients with advanced solid tumorsTakashi Kojima, Kentaro Yamazaki, Ken Kato, et al.
Pageof 25